SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-20-034843
Filing Date
2020-02-13
Accepted
2020-02-13 11:36:06
Documents
1
Group Members
DELAWARE SMALL CAP CORE FUND, A SERIES OF DELAWARE GROUP EQUITY FUNDS IVMACQUARIE BANK LTDMACQUARIE INVESTMENT MANAGEMENT AUSTRIA KAPITALANLAGE AG VIENNAMACQUARIE INVESTMENT MANAGEMENT BUSINESS TRUSTMACQUARIE INVESTMENT MANAGEMENT HOLDINGS INC

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d888917dsc13ga.htm SC 13G/A 140117
  Complete submission text file 0001193125-20-034843.txt   142016
Mailing Address 50 MARTIN PLACE SYDNEY, NSW 2000 C3 2000
Business Address 50 MARTIN PLACE SYDNEY, NSW 2000 C3 2000 212.231.1000
MACQUARIE GROUP LTD (Filed by) CIK: 0001418333 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 3721 VALLEY CENTRE DR. SUITE 200 SAN DIEGO CA 92130
Business Address 3721 VALLEY CENTRE DR. SUITE 200 SAN DIEGO CA 92130 760-260-8600
Retrophin, Inc. (Subject) CIK: 0001438533 (see all company filings)

IRS No.: 262383102 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87088 | Film No.: 20608044
SIC: 2834 Pharmaceutical Preparations